Community Acquired Pneumonia Flashcards
1
Q
Clinical Features of Pneumonia
A
- Cough
- fever
- sputum production
- pleuritic chest pain
2
Q
Causes of pneumonia
A
- poor pulmonary toilet
- Natural tracheal barrier compromised (in VAP)
- Contaminated secretions pool & leak around the ET tube (in VAP)
3
Q
CURB- 65 Definition
A
- C = confusion
- U = Urea > 7; BUN > 20
- R = Resp Rate > 30
- B = Blood Pressure –> systolic < 90; diastolic < 60
- 65 = Age > 65 yrs
4
Q
CURB-65 Significance
A
Each of the 5 criteria is worth 1 pt, add them together:
- 0-1pts: mild pneumonia (there’s only a 3% chance that your patient will go home & die)
- 2 pts: moderate (9%)
- if you’re in the 4s & 5s then you should probably be admitted to the ICU
5
Q
Minor Criteria for Severe CAP
A
- RR > 30breaths/min
- PaO2/FiO2 ratio < 250
- Multi-lobar infiltrates
- Confusion/disorientation
- Uremia (BUN level > 20mg/dL)
- Leukopenia (WBC count < 4000 cells/mm^3)
- Thrombocytopenia (plt count < 100,000 cells/mm^3)
- Hypothermia – core temp < 36 degrees celsius
- Hypotension requiring aggressive fluid resuscitation
6
Q
Major Criteria for Severe CAP
A
- Invasive mechanical ventilation
- Septic shock w/ the need for vasopressors
7
Q
When to admit a CAP patient to the ICU:
A
- must meet 1 Major criteria for severe CAP or 3 minor criteria for severe CAP
8
Q
Outpatient Etiology of CAP
A
- Streptococcus pneumoniae
- Mycoplasma pneumoniae
- Haemophilus influenzae
- Chlamydophila pneumoniae
- Respiratory viruses
9
Q
Inpatient (non-ICU) Etiology of CAP
A
- S. pneumoniae
- M. pneumoniae
- C. pneumoniae
- H. influenzae
- Legionella species
- Aspiration
- Respiratory viruses
10
Q
Inpatient ICU Etiology of CAP
A
- S. pneumoniae
- Staphylococcus aureus
- Legionella species
- Gram-negative bacilli
- H. influenzae
11
Q
Outpatient Treatment of CAP
A
- Previously health & no use of antimicrobials w/in 3 months: a macrolide (1st line; strong rec); alternative: doxycycline (weak rec)
- Presence of comorbidities such as chronic heart, lung, liver, or renal disease; DM; alcoholism; malignancies; asplenia; immunosuppressing conditions or use of immunosuppressing drugs; or use of antimicrobials w/in the previous 3 months (in which case an alternative from a differenct class should be selected): a respiratory FQ (moxi, gemifoxacin, or Levaquin [750mg]) - strong rec; A beta-lactam + macrolide (strong rec) –> beta-lactam must have reasonable activity such as high dose amoxil, augmentin, or a decent cephalosporin
12
Q
Inpatient Non-ICU Treatment of CAP
A
- a respiratory FQ (strong rec)
- a beta lactam + a macrolide (strong rec)
13
Q
Inpatient ICU Treatment of CAP
A
- a beta-lactam (cefotaxime, ceftriaxone, or ampicillin-sulbactam) + either azithromycin (level II) or a respiratory FQ (level I)
- For PCN allergic patients: respiratory FQ & aztreonam
14
Q
When to Switch to PO
A
- Temp < 37.8 degrees celsius
- HR < 100 beats/min
- RR < 24 breaths/min
- Systolic BP > 90mmHg
- Arterial O2 saturation > 90% or pO2 > 60mmHg on room air
- Ability to maintain oral intake
- Normal mental status
15
Q
Duration of therapy
A
- minimum of 5 days (level I)
- should be afebrile for 48-72 hours
- AND should have no more than 1 CAP-associated sign of clinical instability